HRMY
Harmony Biosciences Holdings, Inc. Healthcare - Biotechnology Investor Relations →
Harmony Biosciences Holdings, Inc. (HRMY) closed at $37.27 as of 2026-02-02, trading 0.3% above its 200-week moving average of $37.16. The stock moved further from the line this week, up from -1.9% last week. With a 14-week RSI of 71, HRMY is in overbought territory.
Over the past 237 weeks of data, HRMY has crossed below its 200-week moving average 7 times. On average, these episodes lasted 21 weeks. Historically, investors who bought HRMY at the start of these episodes saw an average one-year return of +20.6%.
With a market cap of $2.1 billion, HRMY is a mid-cap stock. The company generates a free cash flow yield of 8.7%, which is notably high. Return on equity stands at 25.9%, indicating strong profitability. The stock trades at 2.6x book value.
Management has been repurchasing shares, with a 2.9% reduction over three years. HRMY passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 4.7 years, a hypothetical investment of $100 in HRMY would have grown to $142, compared to $168 for the S&P 500. HRMY has returned 7.9% annualized vs 11.7% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: HRMY vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After HRMY Crosses Below the Line?
Across 7 historical episodes, buying HRMY when it crossed below its 200-week moving average produced an average return of +15.7% after 12 months (median +10.0%), compared to +9.3% for the S&P 500 over the same periods. 67% of those episodes were profitable after one year. After 24 months, the average return was -8.5% vs +22.8% for the index.
Each line shows $100 invested at the moment HRMY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
HRMY has crossed below its 200-week MA 7 times with an average 1-year return of +20.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 2021 | Aug 2021 | 4 | 25.0% | +93.9% | +42.5% |
| Jan 2022 | Jan 2022 | 2 | 5.7% | +46.7% | +10.5% |
| May 2022 | May 2022 | 1 | 5.0% | +1.8% | +5.8% |
| Mar 2023 | Sep 2024 | 76 | 51.6% | +2.8% | +14.2% |
| Sep 2024 | Jan 2025 | 15 | 13.9% | -21.2% | +7.7% |
| Feb 2025 | Dec 2025 | 43 | 31.2% | -0.5% | -0.5% |
| Dec 2025 | Ongoing | 6+ | 3.1% | Ongoing | -0.3% |
| Average | 21 | — | +20.6% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02